<?xml version="1.0" encoding="UTF-8"?>
<p>Infantile respiratory viral illnesses have become an increasing cause of morbidity and mortality in populations 0–2 years of age, with approximately 300,000 pediatric hospital admissions annually in the United States and estimated hospital costs ranging from $140 to $800 million annually (Tregoning and Schwarze 
 <xref ref-type="bibr" rid="CR27">2010</xref>; Coffin 
 <xref ref-type="bibr" rid="CR9">2005</xref>; Hustedt and Vazquez 
 <xref ref-type="bibr" rid="CR15">2010</xref>; Smuts et al. 
 <xref ref-type="bibr" rid="CR25">2008</xref>). Lower respiratory tract infections (LRTI) are a leading indication for hospitalization (2–3 %) in young children. Approximately 90 % of LRTI in children are viral, in contrast to adults, in whom approximately 12 % of community-acquired LRTIs have a viral etiology (Hammond et al. 
 <xref ref-type="bibr" rid="CR14">2007</xref>; Chong et al. 
 <xref ref-type="bibr" rid="CR8">2009</xref>; Welliver 
 <xref ref-type="bibr" rid="CR29">2003</xref>).
</p>
